Surgery in rheumatoid arthritis patients under anti-TNF-α therapy: what is the risk?

被引：0
|
作者：
Daniel Wendling
机构：
[1] Franche-Comté University,Department of Rheumatology, University Teaching Hospital
来源：
Clinical Rheumatology | 2007年 / 26卷
关键词：
Rheumatoid Arthritis; Infliximab; Rheumatoid Arthritis Patient; Etanercept; Adalimumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1396 / 1397
页数：1
相关论文
共 50 条
  • [31] Guideline for anti-TNF-α therapy in psoriatic arthritis
    Kyle, S
    Chandler, D
    Griffiths, CEM
    Helliwell, P
    Lewis, J
    McInnes, I
    Oliver, S
    Symmons, D
    McHugh, N
    RHEUMATOLOGY, 2005, 44 (03) : 390 - 397
  • [32] Efficacy of rituximab on pulmonary nodulosis occurring or increasing in patients with rheumatoid arthritis during anti-TNF-α therapy
    De Stefano, R.
    Frati, E.
    Nargi, F.
    Menza, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (04) : 752 - 753
  • [33] Rapid resolution of gastrointestinal amyloidosis and resolution of proteinuria in patients with rheumatoid arthritis treated with anti-TNF-α therapy
    Kuroda, Takeshi
    Kobayashi, Daisuke
    Otaki, Yasuhiro
    Sato, Hiroe
    Nakatsue, Takeshi
    Wada, Yoko
    Murakami, Shuichi
    Saeki, Takako
    Nakano, Masaaki
    Hanyu, Tadamasa
    Gejyo, Fumitake
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S270 - S270
  • [34] Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-α therapy
    Gonzalez-Gay, M. A.
    Vazquez-Rodriguez, T. R.
    Garcia-Unzueta, M. T.
    Berja, A.
    Miranda-Filloy, J. A.
    de Matias, J. M.
    Gonzalez-Juanatey, C.
    Llorca, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (01) : 56 - 62
  • [35] Anti-TNF-α therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data
    Joulfayan, Haroutyun
    Makunts, Tigran
    Abagyan, Ruben
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [36] Anti-TNF-α therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data
    Haroutyun Joulfayan
    Tigran Makunts
    Ruben Abagyan
    Scientific Reports, 13
  • [37] The effect of anti-TNF-α vs. DMARDs on fatigue in rheumatoid arthritis patients
    van Hoogmoed, D.
    Fransen, J.
    Repping-Wuts, H.
    Spee, L.
    Bleijenberg, G.
    van Riel, P. L. C. M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (01) : 15 - 19
  • [38] Influenza vaccine with adjuvant on disease activity in psoriatic arthritis patients under anti-TNF-α therapy
    Caso, F.
    Ramonda, R.
    Del Puente, A.
    Darda, M. A.
    Cantarini, L.
    Peluso, R.
    Esposito, C.
    Ortolan, A.
    Fiocco, U.
    Punzi, L.
    Scarpa, R.
    Costa, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (03) : 507 - 512
  • [39] Effects of anti-TNF-α treatment on lipid profile in patients with active rheumatoid arthritis
    Seriolo, Bruno
    Paolino, Sabrina
    Sulli, Alberto
    Fasciolo, Daniela
    Cutolo, Maurizio
    BASIC AND CLINICAL ASPECTS OF NEUROENDOCRINE IMMUNOLOGY IN RHEUMATIC DISEASES, 2006, 1069 : 414 - 419
  • [40] Detection of tuberculosis by extensive screening in a patient with rheumatoid arthritis prior to anti-TNF-α therapy
    Iseli, A.
    Huellstrung, H. D.
    Rodenhausen, S.
    Widmer, A. F.
    Tyndall, A.
    Hasler, P.
    RHEUMATOLOGY, 2006, 45 (08) : 1049 - 1050
12345